INVESTORS

OVERVIEW

Dedicated to Saving Lives by Transforming At-home Cancer Detection

Clinical laboratory tests save costs and lives by enabling early detection and prevention of disease.

Patients with cancers and other conditions are living longer and enjoying better health because of medical revolutions in diagnostic technology.

At its center are genetic and genomic tests that identify the unique genetic profile of individual patients or their disease and allow physicians to tailor treatment to those unique characteristics.

ColoAlert, Lead Product Highlights

Significant Expertise

Founded in 2008 and located in Mainz, Germany – a world-renowned community for advanced DNA and pharmaceutical research.

Managed by Industry Experts

Mainz Biomed is led by a seasoned management team of global industry veterans supported by board members and scientific advisors.

Publicly Listed

A successful IPO in November 2021 (NASDAQ: MYNZ) fuels the progressing commercialisation, product development and research.

Commercially Ready Flagship Product

Our CE-IVD cleared flagship product ColoAlert is the first DNA-based screening test for colorectal cancer in Europe.

Valuable IP Position

Utilizing PCR-based molecular genetics testing for specific DNA tumor markers as well as proprietary mRNA biomarkers for early CRC and AA detection.

MAINZ BIOMED (NASDAQ: MYNZ) AIMS TO BECOME A LEADER IN THE MULTI-BILLION-DOLLAR COLORECTAL CANCER DIAGNOSTICS MARKET

PROFILE

Suspendisse et blandit nibh. Donec sed erat tempor, vulputate felis at, molestie mi. Proin vitae laoreet purus. Aliquam tempor vestibulum tristique. Ut mollis dui et ante congue, quis consectetur erat venenatis. Nulla eget tempor augue, id porta arcu. Vestibulum vulputate semper augue id condimentum. Ut malesuada vitae diam ut venenatis. Etiam sed erat eu eros fermentum facilisis sit amet sed elit. Curabitur luctus dapibus eleifend. Proin eget mauris velit. Maecenas tincidunt erat ex, efficitur euismod tortor aliquam vel. Ut nec diam et ligula aliquet finibus nec a massa. Etiam at dolor sem. Morbi viverra orci sollicitudin enim sollicitudin, quis lobortis justo pretium. Phasellus ligula eros, hendrerit sed luctus a, pharetra vel arcu.

REGULATORY FILINGS

Aenean commodo, lectus id faucibus fermentum, velit felis euismod turpis, et fermentum turpis ante gravida mauris. Aenean id magna at erat interdum feugiat eu id erat. Duis sed nisi in ex sollicitudin suscipit. Curabitur hendrerit elementum lectus in volutpat. Aenean iaculis, risus ut consequat hendrerit, purus diam tristique mauris, nec consectetur magna tortor quis lectus. Proin varius pulvinar mi at congue. Curabitur non nisl nisl. Fusce ultrices malesuada dui, quis ultrices enim rutrum fermentum.

FIND OUT MORE ABOUT OUR OPPORTUNITY

CLICK THE PREVIEW IMAGE TO
DOWNLOAD OUR PRESENTATION

CONSULTANTS

Suspendisse et blandit nibh. Donec sed erat tempor, vulputate felis at, molestie mi. Proin vitae laoreet purus. Aliquam tempor vestibulum tristique. Ut mollis dui et ante congue, quis consectetur erat venenatis. Nulla eget tempor augue, id porta arcu.

INVESTOR RELATIONS

CONTACT INFORMATION

LEGAL COUNSEL

CONTACT INFORMATION

AUDITORS

CONTACT INFORMATION

TRANSFER AGENT

CONTACT INFORMATION